Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
157.96
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
88
89
Next >
7 New Year’s Stocks to Buy to Get 2024 Off to a Bright Start
December 19, 2023
With one year down and another soon coming up, investors should take the time to consider these stocks to buy for 2024.
Via
InvestorPlace
Why NYSE:JNJ qualifies as a good dividend investing stock.
December 19, 2023
Uncovering Dividend Opportunities with JOHNSON & JOHNSON (NYSE:JNJ).
Via
Chartmill
3 Healthcare Stocks That Could Help Make You a Millionaire
December 19, 2023
These stocks each have reached an important turning point that could signal growth ahead.
Via
The Motley Fool
3 of the Most Attractive Dividend Stocks in the Pharma Space
December 17, 2023
Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere.
Via
InvestorPlace
The Dogs of the Dow May Pay Big Dividends in 2024
December 15, 2023
The dogs of the Dow could be great buys in 2024 for investors looking to take a chance on some underdogs that pay dividends too.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Unusual Options Activity
December 12, 2023
Via
Benzinga
2 Top Dividend Stocks to Buy Now
December 11, 2023
You can snap up these particular dividend stocks for a bargain today.
Via
The Motley Fool
(JNJ) - Analyzing Johnson & Johnson's Short Interest
December 07, 2023
Via
Benzinga
The 7 Most Undervalued Dividend Stocks to Buy in December
December 15, 2023
Enjoy passive income throughout 2024 and watch your investment grow with these dividend stocks to buy this month.
Via
InvestorPlace
AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial
December 15, 2023
AC Immune SA's (NASDAQ: ACIU) development partner has programmed the launch of a Phase 2b clinical study to evaluate ACI-35.030 (JNJ-64042056) in patients with...
Via
Benzinga
3 Dow Stocks I Wouldn’t Touch With a 10-Foot Pole
December 14, 2023
Just because the Dow 30 is supposed to serve as a bellwether for the American economy doesn't mean there aren't some Dow stocks to avoid.
Via
InvestorPlace
Topics
Economy
Stocks
Exposures
Economy
US Equities
Ryan Cohen Plans to Save GameStop By Becoming Warren Buffett
December 14, 2023
Ryan Cohen's latest plan to save GME stock is transforming GameStop into Berkshire Hathaway. Will it work?
Via
InvestorPlace
Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut
December 14, 2023
Rain Oncology Inc (NASDAQ: RAIN) has agreed to be acquired by Pathos AI Inc.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
December 13, 2023
Integra LifeSciences Holdings Corporation (NASDAQ: IART) agreed to acquire Acclarent Inc.
Via
Benzinga
Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability
December 13, 2023
Although some signs of economic progress is seen, other signs suggest that investors should consider defensive stock picks.
Via
InvestorPlace
D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
December 13, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Seeking Passive Income? 7 Dividend Stocks You Don’t Want to Miss.
December 13, 2023
Are you looking for passive income through dividend stocks? Here are seven dividend stocks you don't want to miss.
Via
InvestorPlace
Life-Changing Investments: 3 Stocks That Will Set You Up for the Long Haul
December 11, 2023
Buying stocks with long-term growth potential regardless of the market ensures you will own future-proof investments to create wealth.
Via
InvestorPlace
Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say
December 11, 2023
Friday, Arcellx Inc (NASDAQ: ACLX) announced new data from its Phase 1 expansion study of CART-ddBCMA, now known as anitocabtagene autoleucel (anito-cel) for relapsed and/or
Via
Benzinga
Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions
December 11, 2023
Gilead Sciences Inc (NASDAQ: GILD) faces a severe threat from the rise in drug counterfeiting, a global issue highlighted by the World Health Organization's staggering estimate of up to $431 billion...
Via
Benzinga
5 Phenomenal Stocks in Warren Buffett's "Secret" Portfolio That Are Screaming Buys in 2024
December 11, 2023
The Oracle of Omaha's $610 million hidden portfolio has five amazing bargains hiding in plain sight.
Via
The Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 08, 2023
A weekly look at top trending tickers seeing increased attention from Benzinga users.
Via
Benzinga
7 Tech Stocks to Light Up Your Portfolio This Holiday Season
December 08, 2023
Are you looking for the best tech stocks this holiday season? Here are seven stocks to light up your portfolio this holiday season.
Via
InvestorPlace
Investing in the Aging Population: 3 Healthcare Stocks to Watch
December 07, 2023
America is becoming a much older country on average. These three healthcare stocks are ideally positioned for this demographic shift.
Via
InvestorPlace
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company
December 07, 2023
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has acquired U.S.
Via
Benzinga
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
Johnson & Johnson (NYSE: JNJ) has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer
Via
Benzinga
Elliott Wave Technical Analysis: Johnson & Johnson
December 06, 2023
Looking for longs into wave (v).
Via
Talk Markets
Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential
December 06, 2023
While it might be tempting to jump onboard the top winners in the S&P 500, these bargain stocks might offer superior upside.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Settles Multiple Lawsuits Over Talc Cancer Claims, Eyes Prepackaged Bankruptcy
December 06, 2023
Johnson & Johnson's (NYSE: JNJ) worldwide vice president for litigation, Erik Haas, disclosed recent settlements with several law firms regarding claims linking J&J talc
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3
December 05, 2023
Warren Buffett stocks are typically bought to be held for a long time but sometimes even he finds it necessary to sell.
Via
InvestorPlace
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
88
89
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.